Details for New Drug Application (NDA): 217287
✉ Email this page to a colleague
NDA 217287 describes CUPRIC CHLORIDE, which is a drug marketed by Amneal, Exela Pharma, Rk Pharma, Somerset, and Hospira, and is included in five NDAs. It is available from five suppliers. Additional details are available on the CUPRIC CHLORIDE profile page.
The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Six suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.
The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Six suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.
Summary for 217287
| Tradename: | CUPRIC CHLORIDE |
| Applicant: | Amneal |
| Ingredient: | cupric chloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217287
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217287 | ANDA | Amneal Pharmaceuticals Private Limited | 80830-2301 | 80830-2301-5 | 25 VIAL in 1 CARTON (80830-2301-5) / 10 mL in 1 VIAL (80830-2301-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.4MG COPPER/ML | ||||
| Approval Date: | Jan 26, 2026 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
